Myriad Genetics Cut to Underweight as Piper Questions Path to Profit

Piper Sandler double-downgraded MYGN, saying the current model cannot grow or cut its way to profit.

Myriad Genetics Cut to Underweight as Piper Questions Path to Profit
Credit: Myriad Genetics
Already have an account? Sign in.